A detailed history of J. Safra Sarasin Holding Ag transactions in Abbott Laboratories stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 205,687 shares of ABT stock, worth $28.4 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
205,687
Previous 166,400 23.61%
Holding current value
$28.4 Million
Previous $19 Billion 22.63%
% of portfolio
0.39%
Previous 0.33%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$111.93 - $119.39 $4.4 Million - $4.69 Million
39,287 Added 23.61%
205,687 $23.3 Billion
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $7.16 Million - $8.45 Million
-71,569 Reduced 30.07%
166,400 $19 Billion
Q2 2024

Jul 30, 2024

BUY
$100.73 - $112.44 $24 Million - $26.8 Million
237,969 New
237,969 $24.7 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $242B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.